A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study
Titel:
A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study
Auteur:
Matsuda, Chu Honda, Michitaka Tanaka, Chihiro Kondo, Ken Takahashi, Takao Kosugi, Chihiro Tokunaga, Yukihiko Takemoto, Hiroyoshi Kim, Ho Min Sakamoto, Junichi Oba, Koji Mishima, Hideyuki